Jupiter Neurosciences (NASDAQ: JUNS) expands equity awards for executives and directors
Rhea-AI Filing Summary
Jupiter Neurosciences, Inc. updated executive and director compensation, emphasizing stock-based incentives under its 2025 Equity Incentive Plan. Alison Silva was appointed Chief Operating Officer and President and her base salary increased to $340,200 from $315,000.
Silva received options to purchase up to 600,000 shares, while each independent non-employee director received options for 100,000 shares. The Board also granted discretionary bonus options in lieu of cash to several executives, including 747,783 options to CEO Christer Rosén and 427,304 options to Silva, plus an additional 200,000 options to CFO Saleem Elmasri. These options generally vest over three years starting on September 2, 2026 in equal quarterly installments.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Alison Silva new base salary: $340,200 per year
Alison Silva prior base salary: $315,000 per year
Alison Silva main option grant: 600,000 shares
+5 more
8 metrics
Alison Silva new base salary
$340,200 per year
Amended employment agreement as COO and President
Alison Silva prior base salary
$315,000 per year
Before June 5, 2026 amendment
Alison Silva main option grant
600,000 shares
Options under 2025 Equity Incentive Plan
Independent director option grant
100,000 shares each
Options for each independent non-employee director
CEO Christer Rosén bonus options
747,783 options
Discretionary bonus in lieu of cash
Alison Silva bonus options
427,304 options
Discretionary bonus in lieu of cash
CFO Saleem Elmasri bonus options
325,565 options
Discretionary bonus in lieu of cash
Additional grant to CFO Elmasri
200,000 options
One-time grant recognizing contributions
Key Terms
2025 Equity Incentive Plan, discretionary bonuses, exercise price, vesting, +1 more
5 terms
2025 Equity Incentive Plan financial
"under the Jupiter Neurosciences, Inc. 2025 Equity Incentive Plan (the “Plan”)"
discretionary bonuses financial
"approved discretionary bonuses to the following executives in the form of stock options"
exercise price financial
"with an exercise price equal to the closing price of the Company’s common stock"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"Such option grant vests over three years commencing from September 2, 2026 in equal quarterly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
independent non-employee directors financial
"approved a grant of stock options to each of the Company’s independent non-employee directors"
FAQ
What executive changes did Jupiter Neurosciences (JUNS) disclose on June 5, 2026?
Jupiter Neurosciences appointed Alison Silva as Chief Operating Officer and President. Her employment agreement was amended, and her base salary increased to $340,200 from $315,000, reflecting expanded responsibilities alongside new equity incentive grants.
How did Jupiter Neurosciences (JUNS) change Alison Silva’s compensation?
Alison Silva’s base salary rose to $340,200 from $315,000 and she received options to purchase up to 600,000 shares. She was also granted 427,304 discretionary bonus options, with all options vesting over three years starting September 2, 2026.
What stock option grants did Jupiter Neurosciences (JUNS) directors receive?
Each independent non-employee director was granted options to purchase up to 100,000 shares of common stock. These options were issued under the 2025 Equity Incentive Plan and vest in equal quarterly installments over three years beginning September 2, 2026.
Which Jupiter Neurosciences (JUNS) executives received bonus options in lieu of cash?
Bonus options under the 2025 Equity Incentive Plan went to Christer Rosén (747,783), Alison Silva (427,304), Saleem Elmasri (325,565), Marshall Hayward (259,231), and Alexander Rosén (341,843), substituting stock options for cash bonuses as approved by the Board.
What additional option grant did Jupiter Neurosciences (JUNS) give to CFO Saleem Elmasri?
Beyond his discretionary bonus options, CFO Saleem Elmasri received a one-time grant of options to purchase up to 200,000 shares. This award recognizes his contributions and vests quarterly over three years starting September 2, 2026, subject to continued service.
How do the new Jupiter Neurosciences (JUNS) stock options vest?
Most newly granted options, including those for executives and independent directors, vest over three years. Vesting begins September 2, 2026, in equal quarterly installments, and requires each recipient to remain in service through the applicable vesting dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
